AKATSUKI SAITO (0000-0002-2792-4399)

Personal information

Biography

I am a motivated D.V.M & Ph.D. scientist with 15 years of experiences in virology (especially in retrovirus and flavivirus), molecular biology, primatology and immunology. I have strong analytical ability, superb project design and perform ability, good independent research ability, and an excellent team worker with good communication skills. I have extensive experience and skills in cell culture including primary cells, molecular cloning, animal experiments (mice, humanized-mice and monkeys), gene editing, flow cytometry, ELISA, western blot and real-time PCR. I have received two awards for young investigator. I am an invited reviewer for > 20 peer review manuscripts from scientific journals. I have experience as a teaching mentor for >15 students.

Activities

Collapse all

University of Miyazaki: Miyazaki, JP

2019-12-01 to present | Associate Professor

Employment

AKATSUKI SAITO

https://orcid.org/0000-0002-2792-4399

Personal information

Emails & domains

Verified email domains

Other IDs

Keywords

Countries

Biography

Activities

Employment (5)

University of Miyazaki: Miyazaki, JP

Research Institute for Microbial Diseases, Osaka University: Suita, JP

Aaron Diamond Aids Research Center: New York, NY, US

Japan Foundation for AIDS Prevention : Inuyama, JP

Primate Research Institute, Kyoto University: Inuyama, JP

Education and qualifications (2)

University of Tokyo: Tokyo, JP

University of Miyazaki: Miyazaki, JP

Works (50 of 110)

Urine of Cats with Severe Fever with Thrombocytopenia Syndrome: A Potential Source of Infection Transmission

Nanopore sequencing-based measurement of paramyxovirus RNA editing reveals virus-specific differences in editing efficiency of mRNA, antigenome and genome

Divergent Effects of Circoviridae Capsid Proteins on Type I Interferon Signaling

Genetic regions affecting the replication and pathogenicity of dengue virus type 2

Host ZCCHC3 blocks HIV-1 infection and production through a dual mechanism

Virological characteristics of the SARS-CoV-2 BA.2.86 variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Divergent Effects of Circoviridae Capsid Proteins on Type I Interferon Signaling

Conserved yet Divergent Smc5/6 Complex Degradation by Mammalian Hepatitis B Virus X Protein

Conserved Antagonization of Type I Interferon Signaling by Arterivirus GP5 Proteins

Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera

Conserved Antagonization of Type I Interferon Signaling by Arterivirus GP5 Proteins

Conserved Functions of Orthohepadnavirus X Proteins to Inhibit Type-I Interferon Signaling

Conserved Functions of Orthohepadnavirus X Proteins to Inhibit Type-I Interferon Signaling

Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics

Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Generation of a Porcine Cell Line Stably Expressing Pig TMPRSS2 for Efficient Isolation of Swine Influenza Virus

Generation of porcine PK-15 cells lacking the Ifnar1 or Stat2 gene to optimize the efficiency of viral isolation

Genetic Diversity of Domestic Cat Hepadnavirus in Southern Taiwan

Generation of a porcine cell line stably expressing pig TMPRSS2 for efficient isolation of viruses from pigs with respiratory diseases

Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus

An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.

Virological characteristics of the SARS-CoV-2 XBB.1.5 variant

Generation of porcine PK-15 cells lacking theIfnar1gene to optimize the efficiency of viral isolation

Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism

Development of a direct duplex real-time PCR assay for rapid detection of domestic cat hepadnavirus

Conserved use of the sodium/bile acid cotransporter (NTCP) as an entry receptor by hepatitis B virus and domestic cat hepadnavirus

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening

Global Prevalence of Domestic Cat Hepadnavirus: An Emerging Threat to Cats' Health?

Identification of domestic cat hepadnavirus from a cat blood sample in Japan

Original Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2

Rapid inactivation of Dabie bandavirus (SFTSV) by irradiation with deep-ultraviolet light-emitting diode

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance

The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant

Usefulness of a new DUV-LED device for the control of infection by Escherichia coli, Staphylococcus aureus, mycobacteria and spore-forming bacteria

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

Repeated Intravaginal Inoculation of Zika Virus Protects Cynomolgus Monkeys from Subcutaneous Superchallenge

Generation of a bovine cell line for gene engineering using an HIV-1-based lentiviral vector.

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.

Repeated Intravaginal Inoculation of Zika Virus Protects Cynomolgus Monkeys from Subcutaneous Superchallenge

Development of a novel Macaque-Tropic HIV-1 adapted to cynomolgus macaques

Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay.

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75

Cell response analysis in SARS-CoV-2 infected bronchial organoids

Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes

Peer review (15 reviews for 7 publications/grants)